These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 3736391

  • 21. Mutations causing Gaucher disease.
    Horowitz M, Zimran A.
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate selectable retroviral vectors for Gaucher disease.
    Havenga MJ, Werner AB, Valerio D, van Es HH.
    Gene Ther; 1998 Oct; 5(10):1379-88. PubMed ID: 9930344
    [Abstract] [Full Text] [Related]

  • 23. Gaucher disease: retrovirus-mediated correction of the enzymatic defect in cultured cells.
    Sorge J, Kuhl W, West C, Beutler E.
    Cold Spring Harb Symp Quant Biol; 1986 Oct; 51 Pt 2():1041-6. PubMed ID: 3472750
    [No Abstract] [Full Text] [Related]

  • 24. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts.
    Sengers RC, Lamers KJ, Bakkeren JA, Schretlen ED, Trijbels JM.
    Neuropadiatrie; 1975 Nov; 6(4):377-82. PubMed ID: 241947
    [Abstract] [Full Text] [Related]

  • 25. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S.
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract] [Full Text] [Related]

  • 26. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S, Lehn P.
    J Soc Biol; 2002 Apr; 196(2):175-81. PubMed ID: 12360746
    [Abstract] [Full Text] [Related]

  • 27. The human glucocerebrosidase gene has two functional ATG initiator codons.
    Sorge JA, West C, Kuhl W, Treger L, Beutler E.
    Am J Hum Genet; 1987 Dec; 41(6):1016-24. PubMed ID: 3687939
    [Abstract] [Full Text] [Related]

  • 28. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.
    Ron I, Horowitz M.
    Hum Mol Genet; 2005 Aug 15; 14(16):2387-98. PubMed ID: 16000318
    [Abstract] [Full Text] [Related]

  • 29. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
    Schmitz M, Alfalah M, Aerts JM, Naim HY, Zimmer KP.
    Int J Biochem Cell Biol; 2005 Nov 15; 37(11):2310-20. PubMed ID: 15982918
    [Abstract] [Full Text] [Related]

  • 30. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E.
    Hum Mutat; 2000 Nov 15; 15(2):181-8. PubMed ID: 10649495
    [Abstract] [Full Text] [Related]

  • 31. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
    Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW.
    Chem Biol; 2005 Nov 15; 12(11):1235-44. PubMed ID: 16298303
    [Abstract] [Full Text] [Related]

  • 32. Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.
    Ginns EI, Choudary PV, Tsuji S, Martin B, Stubblefield B, Sawyer J, Hozier J, Barranger JA.
    Proc Natl Acad Sci U S A; 1985 Oct 15; 82(20):7101-5. PubMed ID: 3863141
    [Abstract] [Full Text] [Related]

  • 33. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
    Ginns EI, Brady RO, Pirruccello S, Moore C, Sorrell S, Furbish FS, Murray GJ, Tager J, Barranger JA.
    Proc Natl Acad Sci U S A; 1982 Sep 15; 79(18):5607-10. PubMed ID: 6957882
    [Abstract] [Full Text] [Related]

  • 34. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA.
    Gene Ther; 1995 Oct 15; 2(8):512-20. PubMed ID: 8593601
    [Abstract] [Full Text] [Related]

  • 35. Gaucher disease patient with myoclonus epilepsy and a novel mutation.
    Tajima A, Ohashi T, Hamano S, Higurashi N, Ida H.
    Pediatr Neurol; 2010 Jan 15; 42(1):65-8. PubMed ID: 20004867
    [Abstract] [Full Text] [Related]

  • 36. Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.
    Bahnson AB, Nimgaonkar M, Fei Y, Boggs SS, Robbins PD, Ohashi T, Dunigan J, Li J, Ball ED, Barranger JA.
    Gene Ther; 1994 May 15; 1(3):176-84. PubMed ID: 7584079
    [Abstract] [Full Text] [Related]

  • 37. Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease.
    Cabrera-Salazar MA, Bercury SD, Ziegler RJ, Marshall J, Hodges BL, Chuang WL, Pacheco J, Li L, Cheng SH, Scheule RK.
    Exp Neurol; 2010 Oct 15; 225(2):436-44. PubMed ID: 20673762
    [Abstract] [Full Text] [Related]

  • 38. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
    Havenga M, Valerio D, Hoogerbrugge P, Es H.
    Gene Ther; 1999 Oct 15; 6(10):1661-9. PubMed ID: 10516714
    [Abstract] [Full Text] [Related]

  • 39. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA, Yu XJ, Bahner I, Kohn DB.
    J Clin Invest; 1992 Aug 15; 90(2):342-8. PubMed ID: 1379609
    [Abstract] [Full Text] [Related]

  • 40. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
    Pentchev PG, Neumeyer B, Svennerholm L, Groth CG, Brady RO.
    Am J Hum Genet; 1983 Jul 15; 35(4):621-8. PubMed ID: 6881138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.